238 related articles for article (PubMed ID: 20399204)
1. Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice.
Comelli F; Bettoni I; Colombo A; Fumagalli P; Giagnoni G; Costa B
Eur J Pharmacol; 2010 Jul; 637(1-3):62-9. PubMed ID: 20399204
[TBL] [Abstract][Full Text] [Related]
2. Effect of rimonabant, the cannabinoid CB1 receptor antagonist, on peripheral nerve in streptozotocin-induced diabetic rat.
Liu WJ; Jin HY; Park JH; Baek HS; Park TS
Eur J Pharmacol; 2010 Jul; 637(1-3):70-6. PubMed ID: 20406631
[TBL] [Abstract][Full Text] [Related]
3. Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve.
Costa B; Trovato AE; Colleoni M; Giagnoni G; Zarini E; Croci T
Pain; 2005 Jul; 116(1-2):52-61. PubMed ID: 15936882
[TBL] [Abstract][Full Text] [Related]
4. The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model.
Valsecchi AE; Franchi S; Panerai AE; Rossi A; Sacerdote P; Colleoni M
Eur J Pharmacol; 2011 Jan; 650(2-3):694-702. PubMed ID: 21050844
[TBL] [Abstract][Full Text] [Related]
5. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.
Obrosova IG; Fathallah L; Stevens MJ
Exp Neurol; 2001 Nov; 172(1):211-9. PubMed ID: 11681853
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes.
Zhang YP; Eber A; Yuan Y; Yang Z; Rodriguez Y; Levitt RC; Takacs P; Candiotti KA
Anesthesiology; 2013 Apr; 118(4):945-54. PubMed ID: 23334664
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR
Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice.
Christianson JA; Ryals JM; Johnson MS; Dobrowsky RT; Wright DE
Neuroscience; 2007 Mar; 145(1):303-13. PubMed ID: 17223273
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.
Zhang F; Challapalli SC; Smith PJ
Neuropharmacology; 2009 Aug; 57(2):88-96. PubMed ID: 19501110
[TBL] [Abstract][Full Text] [Related]
10. Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy.
Al-Rejaie SS; Aleisa AM; Abuohashish HM; Parmar MY; Ola MS; Al-Hosaini AA; Ahmed MM
Neurol Res; 2015 Oct; 37(10):924-33. PubMed ID: 26187552
[TBL] [Abstract][Full Text] [Related]
11. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
Kumar A; Kaundal RK; Iyer S; Sharma SS
Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
[TBL] [Abstract][Full Text] [Related]
12. Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade.
Tiwari V; Kuhad A; Chopra K
Phytother Res; 2011 Oct; 25(10):1527-36. PubMed ID: 21394805
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats.
Samii A; Unger J; Lange W
Neurosci Lett; 1999 Mar; 262(3):159-62. PubMed ID: 10218880
[TBL] [Abstract][Full Text] [Related]
14. Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.
Katz NK; Ryals JM; Wright DE
Neuroscience; 2015 Jan; 285():312-23. PubMed ID: 25451280
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats.
Li F; Fang Q; Liu Y; Zhao M; Li D; Wang J; Lu L
Eur J Pharmacol; 2008 Jul; 589(1-3):122-6. PubMed ID: 18534572
[TBL] [Abstract][Full Text] [Related]
16. Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats.
Croci T; Zarini E
Br J Pharmacol; 2007 Mar; 150(5):559-66. PubMed ID: 17245360
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid induces nerve regeneration and increases serum and nerve contents of neural growth factor in experimental diabetic neuropathy.
Hernández-Pedro N; Ordóñez G; Ortiz-Plata A; Palencia-Hernández G; García-Ulloa AC; Flores-Estrada D; Sotelo J; Arrieta O
Transl Res; 2008 Jul; 152(1):31-7. PubMed ID: 18593635
[TBL] [Abstract][Full Text] [Related]
18. Statin treatment reduces oxidative stress-associated apoptosis of sciatic nerve in diabetes mellitus.
Gürpınar T; Ekerbiçer N; Harzadın NU; Barut T; Tarakçı F; Tuglu MI
Biotech Histochem; 2011 Dec; 86(6):373-8. PubMed ID: 20662602
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan inhibits hyperalgesia and inflammatory progression in a diabetic neuropathic pain model of Wistar rats.
Al-Rejaie SS; Abuohashish HM; Ahmed MM; Arrejaie AS; Aleisa AM; AlSharari SD
Neurosciences (Riyadh); 2015 Apr; 20(2):115-23. PubMed ID: 25864063
[TBL] [Abstract][Full Text] [Related]
20. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy.
Hoybergs YM; Meert TF
Neurosci Lett; 2007 May; 417(2):149-54. PubMed ID: 17412508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
